Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Proteomic Signature in Breast Cancer Correlated With Tumor Response in Patients Necessitating a Neo-adjuvant Chemotherapy

NCT00911911 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT00911911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Proteomic Signature in Breast Cancer Correlated With Tumor Response in Patients Necessitating a Neo-adjuvant Chemotherapy
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2007
Completion date
January 16, 2012
Enrollment
66 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer